Pulmonary manifestations of anti-neutrophil cytoplasmic antibody (ANCA)-positive vasculitis

Rheumatology

Volumn 45, Issue 3, 2006, Pages 261-268

  Thickett, D R ^a,b   Richter, A G ^a   Nathani, N ^a   Perkins, G D ^a   Harper, L ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b Lung Investigation Unit   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXYSPERGUALIN; ALPHA INTERFERON; AZATHIOPRINE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; ETANERCEPT; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE; RITUXIMAB; THYMOCYTE ANTIBODY;

ANCA ASSOCIATED VASCULITIS; ARTHRALGIA; BRONCHOSCOPY; CARDIOTOXICITY; CELL PROLIFERATION; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG DOSE REGIMEN; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLU LIKE SYNDROME; HUMAN; HYPERTENSION; IMMUNOFLUORESCENCE TEST; KIDNEY FAILURE; LUNG BIOPSY; LUNG ENDOTHELIUM; LUNG FUNCTION TEST; LUNG HEMORRHAGE; MICROSCOPIC POLYANGIITIS; NEUTROPENIA; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOPATHY; REMISSION; RESPIRATORY TRACT INFECTION; REVIEW; SUBGLOTTIC STENOSIS; WEGENER GRANULOMATOSIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; DIAGNOSIS, DIFFERENTIAL; HUMANS; LUNG DISEASES; TOMOGRAPHY, X-RAY COMPUTED; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 33644870006     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kei217     Document Type: Review

References (91)

1. Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitides: The proposal of an International Consensus Conference. Arthritis Rheum 1994;37:187-92.
2. Watts RA, Lane SE, Bentham G, Scott DG. Epidemiology of systemic vasculitis: A ten-year study in the United Kingdom. Arthritis Rheum 2000;43:414-19.
3. Reinhold-Kelley E, Beuge N, Latza U et al. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: Long-term outcome in 155 patients. Arthritis Rheum 2000;43: 1021-32.
4. Hogan S, Nachman P, Wilkman A, Jennette J, Falk R and the TGDC Network. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-assocaited microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 1996;7:23-32.
5. Hagen EC, Daha MR, Hermans J et al. Diagnostic value of standardized assays for anti neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization Kidney Int. 1998 Mar;53(3):743-53.
6. Specks U, Wheatley CL, McDonald TJ, Rohrbach MS, DeRemee RA. Anticytoplasmic autoantibodies in the diagnosis and follow-up of Wegener's granulomatosis. Mayo Clin Proc 1989; 64:28-36.
7. Travis WD, Hoffman GS, Leavitt RY, Pass HI, Fauci AS. Surgical pathology of the lung in Wegener's granulomatosis. Review of 87 open lung biopsies from 67 patients. Am J Surg Pathol 1991; 15:315-33.
8. Hellmich B, Gross WL. [Churg-Strauss syndrome during treatment with leukotriene receptor antagonists: Demasking by glucocorticoid reduction or a side effect?]. Dtsch Med Wochenschr 2003;128:1469.
9. Williams JM, Kamesh L, Savage CO. Translating basic science into patient therapy for ANCA-associated small vessel vasculitis. Clin Sci (Lond) 2005;108:101-12.
10. Kamesh L, Harper L, Savage CO. ANCA-positive vasculitis. J Am Soc Nephrol 2002;13:1953-60.
11. Xiao H, Heeringa P, Hu P et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 2002;110:955-63.
12. Schuepp B, Pfister H, Clemetson K, Silverstein R, Jungi T. CD36-mediated signal transduction in human monocytes by anti-CD36 antibodies but not by anti-thrombospondin antibodies recognising cell membrane bound thrombospondin. Biochem Biophysics Res Commun 1991;175:263-70.
13. Calderwood JW, Williams JM, Morgan MD, Nash GB, Savage CO. ANCA induces {beta}2 integrin and CXC chemokine-dependent neutrophil-endothelial cell interactions that mimic those of highly cytokine-activated endothelium. J Leukoc Biol 2004;30:30.
14. Brouwer E, Stegeman CA, Huitema G, Limburg PC, Kallenberg CGM. T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG). Clin Exp Immunol 1994;98:448-53.
15. King W, Brooks C, Holder R, Hughes P, Adu D, Savage C. T lymphocyte responses to anti-neutrophil cytoplasmic autoantibody (ANCA) antigens are present in patients with ANCA-associated systemic vasculitis and persist during disease remission. Clin Exp Immunol 1998;112:539-46.
16. Cohen Tervaert J, Popa E, Bos N. The role of superantigens in vasculitis. Curr Opin Rheum 1999;11:24-33.
17. Christensson M, Pettersson E, Sundqvist KG, Christensson B. T cell activation in patients with ANCA-associated vasculitis: Inefficient immune suppression by therapy. Clin Nephrol 2000;54: 435-42.
18. Sneller MC. Granuloma formation, implications for the pathogenesis of vasculitis. Cleve Clin J Med. 2002;69 Suppl 2: S1140-3.
19. Csernok E, Trabandt A, Muller A et al. Cytokine profiles in Wegener's granulomatosis: Predominance of type 1 (Th1) in the granulomatous inflammation. Arthritis Rheum 1999;42:742-50.
20. Muller A, Trabandt A, Gloeckner-Hofmann K et al. Localised Wegener's granulomatosis: Predominance of CD26 and IFNγ expression. J Pathol 2000;192:113-20.
21. Moosig F, Csernok E, Wang G, Gross W. Costimulatory molecules in Wegener's granulomatosis (WG): Lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells. Clin Exp Immunol 1998;114:113-18.
22. Komocsi A, Lamprecht P, Csernok E et al. Peripheral blood and granuloma CD4(+)CD28(-) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener's granulomatosis. Am J Pathol 2002;160:1717-24.
23. Lane SE, Watts RA, Bentham G, Innes NJ, Scott DG. Are environmental factors important in primary-systemic vasculitis? A case-control study. Arthritis Rheum 2003;48:814-23.
24. Jagiello P, Gross WL, Epplen JT. Complex genetics of Wegener granulomatosis. Autoimmun Rev 2005;4:42-7.
25. 1-antitrypsin deficiency and anti-proteinase 3 antibodies in anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis. Clin Exp Immunol 1995;100:844-50.
26. 1-antitrypsin as a determinant of outcome in Pr3-ANCA-positive vasculitis. Kidney Int 1995;48:844-50.
27. Harper L, Cockwell P, Savage C. Case of propylthiouracil-induced ANCA associated small vessel vasculitis. Nephrol Dial Transplant 1998;13:455-8.
28. Choi HK, Slot MC, Pan G, Weissbach CA, Niles JL, Merkel PA. Evaluation of antineutrophil cytoplasmic antibody seroconversion induced by minocycline, sulfasalazine, or penicillamine. Arthritis Rheum 2000;43:2488-92.
29. Stegeman CA, Cohen Tervaert JW, Sluiter WJ, Manson WL, de Jong PE, Kallenberg CGM. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener's granulomatosis. Ann Intern Med 1994;120:12-17.
30. Capizzi SA, Specks U. Does infection play a role in the pathogenesis of pulmonary vasculitis? Semin Respir Infect 2003;18:17-22.
31. Weller PF, Plant M, Taggart V, Trontell A. The relationship of asthma therapy and Churg-Strauss syndrome: NIH workshop summary report. J Allergy Clin Immunol 2001;108:175-83.
32. Schnabel A, Reuter M, Csernok E, Richter C, Gross WL. Subclinical alveolar bleeding in pulmonary vasculitides: Correlation with indices of disease activity. Eur Respir J 1999;14:118-24.
33. Hoffman GS, Kerr GS, Leavitt RY et al. Wegener granulomatosis: An analysis of 158 patients. Ann Intern Med 1992;116:488-98.
34. Chumbley LC, Harrison EG Jr, DeRemee RA. Allergic granulomatosis and angiitis (Churg-Strauss syndrome). Report and analysis of 30 cases. Mayo Clin Proc 1977;52:477-84.
35. Guillevin L, Lhote F, Gayraud M et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. Medicine 1996; 75:17-28.
36. Collard HR, Schwarz MI. Diffuse alveolar hemorrhage. Clin Chest Med 2004;25:583-92, vii.
37. Haworth SJ, Savage CO, Carr D, Hughes JM, Rees AJ. Pulmonary haemorrhage complicating Wegener's granulomatosis and microscopic polyarteritis. Br Med J (Clin Res Educ) 1985;290:1775-8.
38. Lauque D, Cadranel J, Lazor R et al. Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Groupe d'Etudes et de Recherche sur les Maladies 'Orphelines' Pulmonaires (GERM'O'P). Medicine 2000;79:222-33.
39. Schwarz MI, Brown KK. Small vessel vasculitis of the lung. Thorax 2000;55:502-10.
40. Green RJ, Ruoss SJ, Kraft SA, Duncan SR, Berry GJ, Raflin TA. Pulmonary capillaritis and alveolar hemorrhage. Update on diagnosis and management. Chest 1996;110:1305-16.
41. Papazian L, Thomas P, Bregeon F et al. Open-lung biopsy in patients with acute respiratory distress syndrome. Anesthesiology 1998;88:935-44.
42. Herridge MS, Pearson FG, Downey GP. Subglottic stenosis complicating Wegener's granulomatosis: Surgical repair as a viable treatment option. J Thorac Cardiovasc Surg 1996;111:961-6.
43. Lohrmann C, Uhl M, Kotter E, Burger D, Ghanem N, Langer M. Pulmonary manifestations of Wegener granulomatosis: CT findings in 57 patients and a review of the literature. Eur J Radiol 2005;53:471-7.
44. Pinching AJ, Rees AJ, Pussell BA, Lockwood CM, Mitchison RS, Peters DK. Relapses in Wegener's granulomatosis: The role of infection. Br Med J 1980;281:836-8.
45. Schubert F, Muhle C, Schnabel A et al. [High-resolution CT (HRCT) of the lung in Wegener's granulomatosis]. Rofo 1994; 161:19-24.
46. Emoto T, Matsumoto T, Tanaka N, Miura G, Kawamura T, Matsunaga N. HRCT findings of pulmonary complications in non-AIDS immunocompromised patients: Are they useful in differential diagnosis? Radiat Med 2003;21:7-15.
47. Raoof S, Raoof S, Naidich DP. Imaging of unusual diffuse lung diseases. Curr Opin Pulm Med 2004;10:383-9.
48. Pankhurst T, Savage CO, Gordon C, Harper L. Malignancy is increased in ANCA-associated vasculitis. Rheumatology 2004, 43:1532-5.
49. Choi H, Merkel P, Walker A, Niles J. Drug-associated ANCA-positive vasculitis: Prevalence among patients with high titres of anti-MPO antibodies. Arthritis Rheum 2000;43:401-13.
50. Erzurum SC, Underwood GA, Hamilos DL, Waldron JA. Pleural effusion in Churg-Strauss syndrome. Chest 1989;95:1357-9.
51. Bowness P, Davies K, Norsworthy P et al. Hereditary C1q deficiency and systemic lupus erythematosus. Q J Med 1994;87: 455-64.
52. Newall C, Schinke S, Savage CO, Hill S, Harper L. Impairment of lung function, health status and functional capacity in patients with ANCA-associated vasculitis. Rheumatology 2005;3:3.
53. Schwarz M, Mortenson R, Colby T et al. Pulmonary capillaritis. The association with progressive irreversible airflow limitation and hyperinflation. Am Rev Resp Dis 1993;148:507-11.
54. Brugiere O, Raffy O, Sleiman C et al. Progressive obstructive lung disease associated with microscopic polyangiitis. Am J Resp Crit Care Med 1997;155:739-42.
55. Rosenberg D, Weinberger S, Fulmer J, Flye M, Fauci A, Crystal R. Functional correlates of lung involvement in Wegener's granulomatosis. Use of pulmonary function tests in staging and follow-up. Am J Med 1980;69:387-94.
56. Schnabel A, Reuter M, Gloeckner K, Muller-Quernheim J, Gross WL. Bronchoalveolar lavage cell profiles in Wegener's granulomatosis. Respir Med 1999;93:498-506.
57. Schnabel A, Holl-Ulrich K, Dalhoff K, Reuter M, Gross WL. Efficacy of transbronchial biopsy in pulmonary vaculitides. Eur Respir J 1997;10:2738-43.
58. Walton EW. Giant-cell granuloma of the respiratory tract (Wegener's granulomatosis). Br Med J 1958;2:265-70.
59. Jayne D, Rasmussen N, Andrassy K et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003; 349;36-44.
60. de Groot K, Reinhold-Keller E, Fink C, Herlyn K, Gross K. High rate of renal relapses in 71 patients with Wegener's granulomatosis under maintenance of remission with low-dose methotrexate. J Am Soc Nephrol 2001;12:98A.
61. de Groot K, Adu D, Savage C. The value of pulse cyclophosphamide in ANCA-associated vasculitis: Meta-analysis and critical review. Nephrol Dial Transplant 2001;16:2018-27.
62. de Groot K, Rasmussen N, Cohen-Tervaert J-W, Jayne D. Randomised trial of cyclophosphamide versus methotrexate for induction of remission in 'non-renal' ANCA-associated vasculitis. Arthritis Rheum 2005; 52:2461-9.
63. Gayraud M, Guillevin L, le Toumelin P et al. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: Analysis of four prospective trials including 278 patients. Arthritis Rheum 2001;44(3):666-75.
64. Gaskin G, Jayne D. Adjunctive plasma exchange is superior to methylprednisolone in acute renal failure due to ANCA-associated glomerulonephritis. J Am Soc Nephrol 2002;13:2A.
65. Klemmer PJ, Chalermskulrat W, Reif MS, Hogan SL, Henke DC, Falk RJ. Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis. Am J Kidney Dis 2003;42:1149-53.
66. Jayne D, Chapel H, Adu D. Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. Q J Med 2000;93:433-9.
67. The Wegener's Granulomatosis Etanercept Trial (WGET) Research Group. Etanercept plus standard therapy for Wegener's granulomatosis. N Engl J Med 2005;352:351-61.
68. Mitoma H, Horiuchi T, Hatta N et al. Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-alpha. Gastroenterology 2005;128: 376-92.
69. Hellmich B, Schnabel A, Gross W. G-CSF treatment for cyclophosphamide-induced severe neutropenia in Wegener's granulomatosis. Arthritis Rheum 1999;42:1752-6.
70. Slot MC, Tervaert JW, Boomsma MM, Stegeman CA. Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis. Arthritis Rheum 2004;51:269-73.
71. Nowack R, Gobel U, Klooker P, Hergesall O, Andrassy K, van der Woude F. Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: A pilot study of 11 patients with renal involvement. J Am Soc Nephrol 1999;10:1965-71.
72. Langford CA, Talar-Williams C, Sneller MC. Mycophenolate mofetil for remission maintenance in the treatment of Wegener's granulomatosis. Arthritis Rheum 2004;51:278-83.
73. Metzler C, Fink C, Lamprecht P, Gross WL, Reinhold-Keller E. Maintenance of remission with leflunomide in Wegener's granulomatosis. Rheumatology 2004;43:315-20.
74. Keogh KA, Wylam ME, Stone JH, Specks U. Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2005;52:262-8.
75. Ferraro G, Meroni PL, Tincani A et al. Anti-endothelial cell antibodies in patients with Wegener's granulomatosis and micropolyarteritis. Clin Exp Immunol 1990;79:47-53.
76. Birck R, Warnatz K, Lorenz H et al. 15-Deoxyspergualin for refractory Wegener's granulomatosis and microscopic polyangiitis: Results of a multicentre trial. J Am Soc Nephrol 2001;12:191A.
77. Schmitt WH, Birck R, Heinzel PA et al. Prolonged treatment of refractory Wegener's granulomatosis with 15-deoxyspergualin: An open study in seven patients. Nephrol Dial Transplant 2005; 20:1083-92.
78. Schmitt WH, Hagen EC, Neumann I, Nowack R, Flores-Suarez LF, van der Woude FJ. Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): An open study in 15 patients. Kidney Int 2004;65:1440-8.
79. Tatsis E, Schnabel A, Gross WL. Interferon-alpha treatment of four patients with the Churg-Strauss syndrome. Ann Intern Med 1998;129:370-4.
80. Simon HU, Seelbach H, Ehmann R, Schmitz M. Clinical and immunological effects of low-dose IFN-alpha treatment in patients with corticosteroid-resistant asthma. Allergy 2003;58:1250-5.
81. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301-8.
82. Hayes-Bradley C. Hypoxia from vasculitic pulmonary haemorrhage improved by prone position ventilation. Br J Anaesth 2004;92:754-7.
83. Ahmed SH, Aziz T, Cochran J, Highland K. Use of extracorporeal membrane oxygenation in a patient with diffuse alveolar hemorrhage. Chest 2004;126:305-9.
84. Betensley AD, Yankaskas JR. Factor VIIa for alveolar hemorrhage in microscopic polyangiitis. Am J Respir Crit Care Med 2002; 166:1291-2.
85. Henke D, Falk RJ, Gabriel DA. Successful treatment of diffuse alveolar hemorrhage with activated factor VII. Ann Intern Med 2004;140:493-4.
86. Jolly M, Molta C, Hoffman G. Wegener's granulomatosis: Pitfalls in the management of pulmonary disease: A case of Wegener's granulomatosis with a hilar mass. J Rheumatol 2000;27:2511-12.
87. Mayse ML, Greenheck J, Friedman M, Kovitz KL. Successful bronchoscopic balloon dilation of nonmalignant tracheobronchial obstruction without fluoroscopy. Chest 2004;126:634-7.
88. Eagleton LE, Rosher RB, Hawe A, Bilinsky RT. Radiation therapy and mechanical dilation of endobronchial obstruction secondary to Wegener's granulomatosis. Chest 1979;76:609-10.
89. Alaani A, Hogg RP, Drake Lee AB. Wegener's granulomatosis and subglottic stenosis: Management of the airway. J Laryngol Otol 2004;118:786-90.
90. Hoffman GS, Kerr GS, Leavitt RY et al. Wegener's granulomatosis: An analysis of 158 patients. Ann Int Med 1992;116:488-98.
91. Gluth MB, Shinners PA, Kasperbauer JL. Subglottic stenosis associated with Wegener's granulomatosis. Laryngoscope 2003; 113:1304-7.